参考文献/References:
[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61: 69- 90.
[2] Proctor MJ, McMillan DC, Morrison DS, et al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer[J]. Br J Cancer, 2012, 107: 695- 699.
[3] Shah TT, Ahmed H, Kanthabalan A, et al. Focal cryotherapy of localized prostate cancer: a systematic review of the literature[J]. Expert Rev Anticancer Ther, 2014, 14: 1337- 1347.
[4] 常小峰, 连惠波, 汪 维, 等. 冷冻治疗激素难治性前列腺癌[J]. 中国肿瘤外科杂志, 2012, 4: 197- 199.
[5] Mao HL, Zhu ZQ, Chen CD. The androgen receptor in hormone- refractory prostate cancer[J]. Asian J Androl, 2009, 11: 69- 73.
[6] Mulholland DJ, Jiao J, Wu H. Hormone refractory prostate cancer: lessons learned from the PTEN prostate cancer model[J]. Adv Exp Med Biol, 2008, 617: 87- 95.
[7] Goya M, Ishii G, Miyamoto S, et al. Prostate- specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer[J]. Prostate, 2006, 66: 1573- 1584.
[8] Saad F, Segal S, Eastham J. Prostate- specific antigen kinetics and outcomes in patients with bone metastases from castration- resistant prostate cancer treated with or without zoledronic acid[J]. Eur Urol, 2014, 65: 146- 153.
[9] 张 姣, 王海涛, 杨 庆, 等. 化疗前中性粒细胞与淋巴细胞比值对接受多西他赛化疗的去势难治性前列腺癌患者预后的影响[J]. 肿瘤, 2015, 35: 333- 339.
[10] Ide H, Nakashima J, Kono H, et al. Prognostic stratification in patients who received hormonal therapy for prostate- specific antigen recurrence after radical prostatectomy[J]. Jpn J Clin Oncol, 2010, 40: 177- 180.
[11] Xiao WK, Chen D, Li SQ, et al. Prognostic significance of neutrophil- lymphocyte ratio in hepatocellular carcinoma: a meta- analysis[J]. BMC Cancer, 2014, 14: 117.
[12] Lee BS, Lee SH, Son JH. Neutrophil- lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy[J]. Cancer Immunol Immunother, 2016, 65: 141- 150.
[13] Pang W, Lou N, Jin C, et al. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor- related factors to predict lymph node metastasis in patients with gastric cancer[J]. Eur J Gastroenterol Hepatol, 2016, 28: 493- 502.
[14] Asaoka T, Miyamoto A, Maeda S, et al. Prognostic impact of preoperative NLR and CA19- 9 in pancreatic cancer[J]. Pancreatology, 2016, 16: 434- 440.
[15] Cedres S, Torrejon D, Martinez A, et al. Neutrophil to lymphocyte ratio(NLR) as an indicator of poor prognosis in stage Ⅳ non- small cell lung cancer[J]. Clin Transl Oncol, 2012, 14: 864- 869.
[16] Li MX, Liu XM, Zhang XF, et al. Prognostic role of neutrophil- to- lymphocyte ratio in colorectal cancer: a systematic review and meta- analysis[J]. Int J Cancer, 2014, 134: 2403- 2413.
[17] Hu K, Lou L, Ye J, et al. Prognostic role of the neutrophil- lymphocyte ratio in renal cell carcinoma: a meta- analysis[J]. BMJ Open, 2015, 5: e006404.
[18] Koh CH, Bhoo- Pathy N, Ng KL, et al. Utility of pre- treatment neutrophil- lymphocyte ratio and platelet- lymphocyte ratio as prognostic factors in breast cancer[J]. Br J Cancer, 2015, 113: 150- 158.
[19] Gu X, Gao X, Li X, et al. Prognostic significance of neutrophil- to- lymphocyte ratio in prostate cancer: evidence from 16, 266 patients[J]. Sci Rep, 2016, 6: 22089.
[20] Lee H, Jeong SJ, Hong SK, et al. High preoperative neutrophil- lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy[J]. World J Urol, 2016, 34: 821- 827.
[21] Nuhn P, Vaghasia AM, Goyal J, et al. Association of pretreatment neutrophil- to- lymphocyte ratio (NLR) and overall survival (OS)in patients with metastatic castration-resistant prostate cancer(mCRPC) treated with first- line docetaxel[J]. BJU Int, 2014, 114: E11- E17.
相似文献/References:
[1]杨红彩,郭 志,司同国,等.氩氦冷冻消融术前外周血中性粒细胞与淋巴细胞比值对原发性肝癌患者预后的影响[J].介入放射学杂志,2017,(01):30.
YANG Hong- cai,GUO Zhi,SI Tong- guo,et al.The neutrophil- to- lymphocyte ratio in peripheral blood in patients with hepatocellular carcinoma before argon- helium cryoablation: its influence on the prognosis[J].journal interventional radiology,2017,(03):30.
[2]蔡智源,何朝滨,陈 尚,等.肝内胆管癌TACE治疗患者的预后因素分析[J].介入放射学杂志,2021,30(03):291.
CAI Zhiyuan,HE Chaobin,CHEN Shang,et al.Analysis of prognostic factors in patients with intrahepatic cholangiocarcinoma after receiving transcatheter arterial chemoembolization[J].journal interventional radiology,2021,30(03):291.